 |
|
Feasibility of Eliminating Ocular Chlamydia trachomatis With Repeat Mass Antibiotic Treatments
Muluken Melese, MD, MPH;
Jaya Devi Chidambaram, MBBS;
Wondu Alemayehu, MD, MPH;
David Chung Lee, BSc;
Elizabeth H. Yi;
Vicky Cevallos, BSc;
Zhaoxia Zhou;
Cathy Donnellan;
Michael Saidel, MD;
John P. Whitcher, MD, MPH;
Bruce D. Gaynor, MD;
Thomas M. Lietman, MD
JAMA. 2004;292:721-725.
Context Mass antibiotic administrations for ocular chlamydial infection play a key role in the World Health Organization's trachoma control program. Mathematical models suggest that it is possible to eliminate trachoma locally with repeat mass treatment, depending on the coverage level of the population, frequency of mass treatments, and rate that infection returns into a community after each mass treatment. Precise estimates of this latter parameter have never been reported.
Objective To determine the rate at which chlamydial infection returns to a population after mass treatment and to estimate the treatment frequency required for elimination of ocular chlamydia from a community.
Design, Setting, and Participants Longitudinal cohort study of 24 randomly selected villages from the Gurage Zone in Ethiopia conducted February 2003 to October 2003. A total of 1332 children aged 1 to 5 years were monitored for prevalence of ocular chlamydial infection pretreatment and 2 and 6 months posttreatment.
Interventions All individuals older than 1 year were eligible for single-dose oral azithromycin treatment. Pregnant women were offered tetracycline eye ointment.
Main Outcome Measures Prevalence of ocular chlamydial infection, measured by polymerase chain reaction, in children aged 1 to 5 years, in each of 24 villages at each time point was used to estimate the rate of return of infection and the treatment frequency necessary for elimination.
Results The prevalence of infection was 56.3% pretreatment (95% confidence interval [CI], 47.5%-65.1%), 6.7% 2 months posttreatment (95% CI, 4.2%-9.2%), and 11.0% 6 months posttreatment (95% CI, 7.3%-14.7%). Infection returned after treatment at an exponential rate of 12.3% per month (95% CI, 4.6%-19.9% per month). The minimum treatment frequency necessary for elimination was calculated to be once every 11.6 months (95% CI, 7.2-30.9 months), given a coverage level of 80%. Thus, biannual treatment, already being performed in some areas, was estimated to be more than frequent enough to eventually eliminate infection.
Conclusion The rate at which ocular chlamydial infection returns to a community after mass treatment suggests that elimination of infection in a hyperendemic area is feasible with biannual mass antibiotic administrations and attainable coverage levels.
Author Affiliations: ORBIS International, Addis Ababa, Ethiopia (Drs Melese and Alemayehu); WHO Collaborating Center, F.I. Proctor Foundation (Drs Chidambaram, Saidel, Whitcher, Gaynor, and Lietman, Mr Lee, and Mss Yi, Cevallos, Zhou, and Donnellan), Department of Ophthalmology (Drs Gaynor, Whitcher, and Lietman), Department of Epidemiology and Biostatistics (Drs Whitcher and Lietman), Institute for Global Health (Drs Whitcher and Lietman), University of California, San Francisco.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
The impact of community level treatment and preventative interventions on trachoma prevalence in rural Ethiopia
Cumberland et al.
Int J Epidemiol 2008;37:549-558.
ABSTRACT
| FULL TEXT
The Molecular Epidemiology of Ocular Chlamydia trachomatis Infections in Western Australia: Implications for Trachoma Control
Porter et al.
Am J Trop Med Hyg 2008;78:514-517.
ABSTRACT
| FULL TEXT
Comparison of Annual and Biannual Mass Antibiotic Administration for Elimination of Infectious Trachoma
Melese et al.
JAMA 2008;299:778-784.
ABSTRACT
| FULL TEXT
Mass Antibiotic Administration for Eradication of Ocular Chlamydia trachomatis
Mabey and Solomon
JAMA 2008;299:819-821.
FULL TEXT
Topical azithromycin: new evidence?
Kuper and Wormald
Br. J. Ophthalmol. 2007;91:566-567.
FULL TEXT
Trachoma and Ocular Chlamydia trachomatis Were Not Eliminated Three Years after Two Rounds of Mass Treatment in a Trachoma Hyperendemic Village
West et al.
IOVS 2007;48:1492-1497.
ABSTRACT
| FULL TEXT
Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma
Yang et al.
Br. J. Ophthalmol. 2007;91:293-295.
ABSTRACT
| FULL TEXT
CHLAMYDIA ON CHILDREN AND FLIES AFTER MASS ANTIBIOTIC TREATMENT FOR TRACHOMA
LEE et al.
Am J Trop Med Hyg 2007;76:129-131.
ABSTRACT
| FULL TEXT
Trachoma, antibiotics and randomised controlled trials.
Shapiro et al.
Br. J. Ophthalmol. 2006;90:1443-1444.
FULL TEXT
Elimination of trachoma: are we in danger of being blinded by the randomised controlled trial?
Wright et al.
Br. J. Ophthalmol. 2006;90:1339-1342.
FULL TEXT
Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection.
Atik et al.
JAMA 2006;296:1488-1497.
ABSTRACT
| FULL TEXT
Effect of a Single Mass Antibiotic Distribution on the Prevalence of Infectious Trachoma
Chidambaram et al.
JAMA 2006;295:1142-1146.
ABSTRACT
| FULL TEXT
Fitness Cost Due to Mutations in the 16S rRNA Associated with Spectinomycin Resistance in Chlamydia psittaci 6BC
Binet and Maurelli
Antimicrob. Agents Chemother. 2005;49:4455-4464.
ABSTRACT
| FULL TEXT
Systemic Antibiotics for Communitywide Trachoma Control
Arch Ophthalmol 2005;123:687-688.
FULL TEXT
SEASONAL EFFECTS IN THE ELIMINATION OF TRACHOMA
LEE et al.
Am J Trop Med Hyg 2005;72:468-470.
ABSTRACT
| FULL TEXT
Single-Dose Azithromycin for Trachoma
Lietman et al.
NEJM 2005;352:414-415.
FULL TEXT
Mass Treatment and the Effect on the Load of Chlamydia trachomatis Infection in a Trachoma-Hyperendemic Community
West et al.
IOVS 2005;46:83-87.
ABSTRACT
| FULL TEXT
From the Library
Br. J. Ophthalmol. 2004;88:1482-1482.
FULL TEXT
|
